Agios Pharmaceuticals (AGIO) Receivables - Other: 2013-2025
Historic Receivables - Other for Agios Pharmaceuticals (AGIO) over the last 10 years, with Sep 2025 value amounting to $5.0 million.
- Agios Pharmaceuticals' Receivables - Other rose 61.29% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 61.29%. This contributed to the annual value of $4.1 million for FY2024, which is 46.23% up from last year.
- Agios Pharmaceuticals' Receivables - Other amounted to $5.0 million in Q3 2025, which was up 0.86% from $5.0 million recorded in Q2 2025.
- Over the past 5 years, Agios Pharmaceuticals' Receivables - Other peaked at $8.1 million during Q2 2021, and registered a low of $1.2 million during Q3 2023.
- In the last 3 years, Agios Pharmaceuticals' Receivables - Other had a median value of $3.3 million in 2025 and averaged $3.3 million.
- In the last 5 years, Agios Pharmaceuticals' Receivables - Other plummeted by 68.84% in 2023 and then surged by 165.14% in 2024.
- Quarterly analysis of 5 years shows Agios Pharmaceuticals' Receivables - Other stood at $7.0 million in 2021, then tumbled by 46.01% to $2.2 million in 2022, then increased by 27.38% to $2.8 million in 2023, then surged by 46.23% to $4.1 million in 2024, then soared by 61.29% to $5.0 million in 2025.
- Its Receivables - Other was $5.0 million in Q3 2025, compared to $5.0 million in Q2 2025 and $3.3 million in Q1 2025.